The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305)
The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
🩺 Plain-English Summary (8th-Grade Level)
The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpose to improve patients' survival, local, and regional tumor control and quality of life.
Who can join: Review the eligibility criteria below.
Location: Allegheny Health Network — Pittsburgh, Pennsylvania
Age range: 18 Years
🧪 Interventions in This Study
- Radiation therapy (RADIATION)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Allegheny Health Network — Pittsburgh, Pennsylvania
- Md Anderson Cancer Center — Houston, Texas
- Medical College of Wisconsin — Milwaukee, Wisconsin
- Austin Health - Olivia Newton-John Cancer Wellness and Research Centre — Melbourne,
- Insitut Jules Bordet — Brussels,
- Sunnybrook Health Sciences Centre/Odette Cancer Centre — Toronto, Ontario
- University Health Network - Princess Margaret Cancer Center — Toronto,
- Odense Universitetshospital — Odense, Funen
- Universitätsklinikum Tübingen — Tübingen,
- Università degli Studi di Brescia — Brescia,
- IRCCS Ospedale Sacro Cuore Don Calabria — Negrar,
- Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital — Amsterdam,
- Radiotherapiegroep — Deventer,
- Radiotherapeutisch Instituut Friesland (RIF) — Leeuwarden,
- Radboud UMC — Nijmegen,
- University Medical Center Utrecht — Utrecht,
- The Royal Marsden and The Institute of Cancer Research National Institute for Health Research Biomedical Research Centre — London,
- The Christie National Health Service Foundation Trust — Manchester,
📞 Contact the Study Coordinator
Phone: T +31 (0)88 75 63707
Email: T.Leer@umcutrecht.nl
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Oncology
- Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation — Miami, Florida
- Ask Questions About Clinical Trials — Bay City, Michigan
- A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors — San Francisco, California
- xPedite: A Study to Expedite DIPG and DMG Research — Los Altos, California
- STEP2 vs. Routine Early Palliative Care: Randomized Noninferiority Trial — Toronto, Ontario
Explore by condition: All Oncology clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.